New Endometrial Sampler Cleared

- Utepreva announced FDA clearance for a single‑use endometrial sampling device intended to support early office‑based evaluation for endometrial cancer in at‑risk women. - The cleared product is described as a disposable, office‑level sampler designed to obtain endometrial tissue for early diagnostic workup. - The clearance suggests labs may see new outpatient‑collected endometrial specimens and should assess adequacy standards, training needs and downstream processing workflows (clpmag.com)